NSC228155
- Product Name
- NSC228155
- CAS No.
- 113104-25-9
- Chemical Name
- NSC228155
- Synonyms
- NSC228155;NSC-228155;NSC 228155;NSC228155;NSC-228155;NSC 228155;2,1,3-Benzoxadiazole, 4-nitro-7-[(1-oxido-2-pyridinyl)thio]-;2-[(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)thio]pyridine 1-oxide;Epidermal growth factor receptor,Histone Acetyltransferase,EGFR,HER1,HATs,inhibit,Inhibitor,NSC-228155,HAT,Epigenetic Reader Domain,NSC 228155,ErbB-1
- CBNumber
- CB13159458
- Molecular Formula
- C11H6N4O4S
- Formula Weight
- 290.25
- MOL File
- 113104-25-9.mol
NSC228155 Property
- Boiling point:
- 627.3±65.0 °C(Predicted)
- Density
- 1.72±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C(protect from light)
- solubility
- ≥29 mg/mL in DMSO; insoluble in H2O; insoluble in EtOH
- form
- solid
- pka
- -1.48±0.10(Predicted)
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- 28856
- Product name
- NSC 228155
- Packaging
- 5mg
- Price
- $68
- Updated
- 2024/03/01
- Product number
- 28856
- Product name
- NSC 228155
- Packaging
- 10mg
- Price
- $121
- Updated
- 2024/03/01
- Product number
- 28856
- Product name
- NSC 228155
- Packaging
- 25mg
- Price
- $235
- Updated
- 2024/03/01
- Product number
- CS-0020796
- Product name
- NSC228155
- Purity
- >98.0%
- Packaging
- 5mg
- Price
- $50
- Updated
- 2021/12/16
- Product number
- CS-0020796
- Product name
- NSC228155
- Purity
- >98.0%
- Packaging
- 50mg
- Price
- $280
- Updated
- 2021/12/16
NSC228155 Chemical Properties,Usage,Production
Biological Activity
nsc228155 is a potent inhibitor of kix-kid interaction.cyclic-amp response-element binding protein (creb) is identified as a stimulus-activated transcription factor. its transcription activity needs its binding with creb-binding protein (cbp) after creb is phosphorylated at ser133. the domains involved for creb-cbp interaction are kinase-inducible domain (kid) from creb and kid-interacting domain (kix) from cbp.
in vitro
previous study found that nsc228155 could dose-dependently inhibit kix–kid interaction as measured by the split rluc assay. in living hek 293t cells, nsc228155 could inhibit creb-mediated gene transcription with an ic50 of 2.09 μm. nsc228155 also inhibited vp16-creb-mediated gene transcription with an ic50 of 6.14 μm. though this was around 3-fold higher than the ic50 of creb-mediated gene transcription, such results indicated that nsc228155 was not particularly selective in inhibiting kix–kid interaction inside these living cells. therefore, although nsc228155 was a potent inhibitor of kix-kid interaction, it was not selective against creb-mediated gene transcription, and further sar studies identified a 4-aniline substituted analog displaying a higher selectivity index [1].
target
| EGFR
| KIX-KID 0.36 μM (IC 50 ) |
IC 50
0.36 μm for kix-kid interaction
References
[1] xie f, li bx, broussard c, xiao x. identification, synthesis and evaluation of substituted benzofurazans as inhibitors of creb-mediated gene transcription. bioorg med chem lett. 2013 oct 1;23(19):5371-5.
NSC228155 Preparation Products And Raw materials
Raw materials
Preparation Products
NSC228155 Suppliers
- Tel
- +1-708-310-1919 +1-13798911105
- Fax
- 708-557-7486
- sales@invivochem.cn
- Country
- United States
- ProdList
- 6393
- Advantage
- 58
- Tel
- +1-833-552-7181
- sales@aladdinsci.com
- Country
- United States
- ProdList
- 57511
- Advantage
- 58
- Tel
- +1-781-999-5354
- support@targetmol.com
- Country
- United States
- ProdList
- 19973
- Advantage
- 58